GSK plc - Asset Resilience Ratio

Latest as of June 2026: 0.00%

GSK plc (GSK) has an Asset Resilience Ratio of 0.00% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read GSK total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

GBX1.00 Million
≈ $121.67 USD Cash + Short-term Investments

Total Assets

GBX61.74 Billion
≈ $7.51 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (1986–2025)

This chart shows how GSK plc's Asset Resilience Ratio has changed over time. See GSK FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down GSK plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see GSK plc balance sheet assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents GBX0.00 0%
Short-term Investments GBX1.00 Million 0.0%
Total Liquid Assets GBX1.00 Million 0.00%

Asset Resilience Insights

  • Limited Liquidity: GSK plc maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

GSK plc Industry Peers by Asset Resilience Ratio

Compare GSK plc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Merck & Company Inc
NYSE:MRK 		Drug Manufacturers - General 0.22%
Novartis AG ADR
NYSE:NVS 		Drug Manufacturers - General 0.06%
Roche Holding AG
SW:ROP 		Drug Manufacturers - General 9.82%
Novartis AG
SW:NOVN 		Drug Manufacturers - General 0.08%
Virbac SA
PA:VIRP 		Drug Manufacturers - General 0.23%
AstraZeneca PLC
LSE:AZN 		Drug Manufacturers - General 0.06%
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019 		Drug Manufacturers - General 0.53%
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SHE:300357 		Drug Manufacturers - General 9.91%

Annual Asset Resilience Ratio for GSK plc (1986–2025)

The table below shows the annual Asset Resilience Ratio data for GSK plc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.01% GBX9.00 Million
≈ $1.10K		 GBX61.12 Billion
≈ $7.44 Million		 -0.02pp
2024-12-31 0.04% GBX21.00 Million
≈ $2.56K		 GBX59.46 Billion
≈ $7.23 Million		 -3.77pp
2023-12-31 3.81% GBX2.25 Billion
≈ $273.27K		 GBX59.01 Billion
≈ $7.18 Million		 -3.10pp
2022-12-31 6.91% GBX4.15 Billion
≈ $505.42K		 GBX60.15 Billion
≈ $7.32 Million		 +6.83pp
2021-12-31 0.08% GBX61.00 Million
≈ $7.42K		 GBX79.10 Billion
≈ $9.62 Million		 -0.02pp
2020-12-31 0.10% GBX78.00 Million
≈ $9.49K		 GBX80.43 Billion
≈ $9.79 Million		 0.00pp
2019-12-31 0.10% GBX79.00 Million
≈ $9.61K		 GBX79.69 Billion
≈ $9.70 Million		 -0.05pp
2018-12-31 0.14% GBX84.00 Million
≈ $10.22K		 GBX58.07 Billion
≈ $7.06 Million		 +0.01pp
2017-12-31 0.14% GBX78.00 Million
≈ $9.49K		 GBX56.38 Billion
≈ $6.86 Million		 -0.01pp
2016-12-31 0.15% GBX89.00 Million
≈ $10.83K		 GBX59.08 Billion
≈ $7.19 Million		 +0.01pp
2015-12-31 0.14% GBX75.00 Million
≈ $9.13K		 GBX53.45 Billion
≈ $6.50 Million		 -0.03pp
2014-12-31 0.17% GBX69.00 Million
≈ $8.40K		 GBX40.65 Billion
≈ $4.95 Million		 +0.01pp
2013-12-31 0.16% GBX66.00 Million
≈ $8.03K		 GBX42.09 Billion
≈ $5.12 Million		 -0.04pp
2012-12-31 0.20% GBX81.00 Million
≈ $9.86K		 GBX41.48 Billion
≈ $5.05 Million		 -0.25pp
2011-12-31 0.45% GBX184.00 Million
≈ $22.39K		 GBX41.08 Billion
≈ $5.00 Million		 +0.01pp
2010-12-31 0.44% GBX184.00 Million
≈ $22.39K		 GBX42.23 Billion
≈ $5.14 Million		 -0.49pp
2009-12-31 0.93% GBX397.00 Million
≈ $48.30K		 GBX42.86 Billion
≈ $5.22 Million		 -2.24pp
2008-12-31 3.17% GBX1.25 Billion
≈ $151.72K		 GBX39.39 Billion
≈ $4.79 Million		 -0.55pp
2007-12-31 3.72% GBX1.15 Billion
≈ $140.44K		 GBX31.03 Billion
≈ $3.78 Million		 -0.33pp
2006-12-31 4.05% GBX1.03 Billion
≈ $125.88K		 GBX25.54 Billion
≈ $3.11 Million		 +0.28pp
2005-12-31 3.77% GBX1.02 Billion
≈ $124.66K		 GBX27.19 Billion
≈ $3.31 Million		 -2.91pp
2004-12-31 6.68% GBX1.51 Billion
≈ $183.90K		 GBX22.64 Billion
≈ $2.75 Million		 -3.72pp
2003-12-31 10.40% GBX2.49 Billion
≈ $302.93K		 GBX23.94 Billion
≈ $2.91 Million		 +4.05pp
2002-12-31 6.35% GBX1.42 Billion
≈ $172.41K		 GBX22.33 Billion
≈ $2.72 Million		 -0.95pp
2001-12-31 7.30% GBX1.60 Billion
≈ $195.11K		 GBX21.97 Billion
≈ $2.67 Million		 -3.39pp
2000-12-31 10.69% GBX2.31 Billion
≈ $280.94K		 GBX21.59 Billion
≈ $2.63 Million		 -6.08pp
1999-12-31 16.77% GBX1.75 Billion
≈ $212.80K		 GBX10.43 Billion
≈ $1.27 Million		 -0.83pp
1998-12-31 17.60% GBX1.65 Billion
≈ $200.15K		 GBX9.35 Billion
≈ $1.14 Million		 +0.45pp
1997-12-31 17.15% GBX1.45 Billion
≈ $176.06K		 GBX8.44 Billion
≈ $1.03 Million		 +5.11pp
1996-12-31 12.04% GBX1.00 Billion
≈ $121.79K		 GBX8.31 Billion
≈ $1.01 Million		 -0.15pp
1995-12-31 12.19% GBX1.04 Billion
≈ $126.66K		 GBX8.54 Billion
≈ $1.04 Million		 -22.15pp
1994-06-30 34.33% GBX2.71 Billion
≈ $329.49K		 GBX7.89 Billion
≈ $959.62K		 +1.70pp
1993-06-30 32.64% GBX2.43 Billion
≈ $296.15K		 GBX7.46 Billion
≈ $907.42K		 +2.28pp
1992-06-30 30.36% GBX1.73 Billion
≈ $209.88K		 GBX5.68 Billion
≈ $691.34K		 -6.11pp
1991-06-30 36.47% GBX2.10 Billion
≈ $254.90K		 GBX5.74 Billion
≈ $698.88K		 +6.95pp
1990-06-30 29.52% GBX1.33 Billion
≈ $161.34K		 GBX4.49 Billion
≈ $546.55K		 +8.79pp
1989-06-30 20.73% GBX719.00 Million
≈ $87.48K		 GBX3.47 Billion
≈ $422.08K		 -18.76pp
1988-06-30 39.48% GBX1.13 Billion
≈ $137.73K		 GBX2.87 Billion
≈ $348.83K		 +0.81pp
1987-06-30 38.68% GBX912.00 Million
≈ $110.96K		 GBX2.36 Billion
≈ $286.90K		 +7.78pp
1986-06-30 30.89% GBX557.00 Million
≈ $67.77K		 GBX1.80 Billion
≈ $219.37K		 --
pp = percentage points

About GSK plc

LSE:GSK UK Drug Manufacturers - General
Market Cap
$853.19 Million
GBX7.01 Trillion GBX
Market Cap Rank
#9604 Global
#34 in UK
Share Price
GBX1750.00
Change (1 day)
+0.84%
52-Week Range
GBX1620.00 - GBX2268.00
All Time High
GBX2268.00
Categories
Companies in UK Drug Manufacturers - General
About

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, infl… Read more